Certolizumab Pegol [certolizumab pegol]

topical
48
Terms

certolizumab pegovaný
Cimzia
kertolizumab pegol

 

CDP 870
CDP870
Cimzia

Persistent link   https://www.medvik.cz/link/D000068582
Definition

A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.

DUI
D000068582 MeSH Browser
CUI
M0507051
History note
2016 (2003)
Public note
2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015

Allowable subheadings

AD
administration & dosage 12
AE
adverse effects 6
AN
analysis
BI
biosynthesis
BL
blood
CF
cerebrospinal fluid
CH
chemistry
CL
classification
DE
drug effects
EC
economics 1
GE
genetics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism 1
PK
pharmacokinetics 2
PD
pharmacology 11
PH
physiology
PO
poisoning
RE
radiation effects
TU
therapeutic use 21
TO
toxicity
UL
ultrastructure
UR
urine

D Chemicals and Drugs
D05 Macromolecular Substances 103
D05.750 Polymers 1 059
D05.750.741 Polyethylene Glycols 401
D05.750.741.125 Certolizumab Pegol 48
D05.750.741.250 Cetomacrogol 2
D05.750.741.485 Hydrogel, Polyethylene Glycol Dimethacrylate 25
D05.750.741.575 Nonoxynol 4
D05.750.741.610 Octoxynol 8
D05.750.741.630 Polidocanol 3
D05.750.741.650 Poloxalene
D05.750.741.667 Poloxamer 14
D05.750.741.685 Polyhydroxyethyl Methacrylate 45
D05.750.741.700 Polysorbates 32
D12 Amino Acids, Peptides, and Proteins 16
D12.644 Peptides 1 389
D12.644.541 Peptide Fragments 369
D12.644.541.500 Immunoglobulin Fragments 187
D12.644.541.500.650 Immunoglobulin Fab Fragments 65
D12.644.541.500.650.125 Abciximab 14
D12.644.541.500.650.250 Certolizumab Pegol 48
D12.644.541.500.650.500 Immunoglobulin Variable Region 36
D12.644.541.500.650.750 Tuftsin 5
D12.776 Proteins 2 584
D12.776.124 Blood Proteins 910
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 493
D12.776.124.486.485.114 Antibodies 1 816
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 693
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 935
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 353
D12.776.124.486.485.114.224.060.313 Alemtuzumab 125
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 453
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 44
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 48
D12.776.124.486.485.114.224.060.750 Cetuximab 186
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 157
D12.776.124.486.485.114.224.060.790 Gemtuzumab 18
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.486.485.114.224.060.798 Ipilimumab 267
D12.776.124.486.485.114.224.060.813 Natalizumab 158
D12.776.124.486.485.114.224.060.829 Nivolumab 459
D12.776.124.486.485.114.224.060.844 Omalizumab 114
D12.776.124.486.485.114.224.060.860 Palivizumab 13
D12.776.124.486.485.114.224.060.864 Panitumumab 62
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 63
D12.776.124.486.485.114.224.060.875 Trastuzumab 278
D12.776.124.486.485.114.224.060.937 Ustekinumab 124
D12.776.124.486.485.680 Immunoglobulin Fragments 187
D12.776.124.486.485.680.650 Immunoglobulin Fab Fragments 65
D12.776.124.486.485.680.650.125 Abciximab 14
D12.776.124.486.485.680.650.250 Certolizumab Pegol 48
D12.776.124.486.485.680.650.500 Immunoglobulin Variable Region 36
D12.776.124.486.485.680.650.750 Tuftsin 5
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 493
D12.776.124.790.651.114 Antibodies 1 816
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 693
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 935
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 353
D12.776.124.790.651.114.224.060.375 Alemtuzumab 125
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 453
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 44
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 48
D12.776.124.790.651.114.224.060.750 Cetuximab 186
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 157
D12.776.124.790.651.114.224.060.790 Gemtuzumab 18
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.790.651.114.224.060.798 Ipilimumab 267
D12.776.124.790.651.114.224.060.813 Natalizumab 158
D12.776.124.790.651.114.224.060.829 Nivolumab 459
D12.776.124.790.651.114.224.060.844 Omalizumab 114
D12.776.124.790.651.114.224.060.860 Palivizumab 13
D12.776.124.790.651.114.224.060.864 Panitumumab 62
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 63
D12.776.124.790.651.114.224.060.875 Trastuzumab 278
D12.776.124.790.651.114.224.060.937 Ustekinumab 124
D12.776.124.790.651.680 Immunoglobulin Fragments 187
D12.776.124.790.651.680.650 Immunoglobulin Fab Fragments 65
D12.776.124.790.651.680.650.125 Abciximab 14
D12.776.124.790.651.680.650.250 Certolizumab Pegol 48
D12.776.124.790.651.680.650.500 Immunoglobulin Variable Region 36
D12.776.124.790.651.680.650.750 Tuftsin 5
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 493
D12.776.377.715.548.114 Antibodies 1 816
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 693
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 935
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 353
D12.776.377.715.548.114.224.200.375 Alemtuzumab 125
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 453
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 44
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 48
D12.776.377.715.548.114.224.200.750 Cetuximab 186
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 157
D12.776.377.715.548.114.224.200.790 Gemtuzumab 18
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 12
D12.776.377.715.548.114.224.200.798 Ipilimumab 267
D12.776.377.715.548.114.224.200.813 Natalizumab 158
D12.776.377.715.548.114.224.200.829 Nivolumab 459
D12.776.377.715.548.114.224.200.844 Omalizumab 114
D12.776.377.715.548.114.224.200.860 Palivizumab 13
D12.776.377.715.548.114.224.200.864 Panitumumab 62
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 63
D12.776.377.715.548.114.224.200.875 Trastuzumab 278
D12.776.377.715.548.114.224.200.937 Ustekinumab 124
D12.776.377.715.548.680 Immunoglobulin Fragments 187
D12.776.377.715.548.680.650 Immunoglobulin Fab Fragments 65
D12.776.377.715.548.680.650.125 Abciximab 14
D12.776.377.715.548.680.650.250 Certolizumab Pegol 48
D12.776.377.715.548.680.650.500 Immunoglobulin Variable Region 36
D12.776.377.715.548.680.650.750 Tuftsin 5

Back Add